Article

Validate Real-World Data-based Endpoint Measures of Cancer Treatment Outcomes

2021-06-16

Abstract excerpt

Recently, there is a growing interest in using real-world data (RWD) to generate real-world evidence (RWE) that complements clinical trials. Nevertheless, to quantify the treatment effects, it is important to develop meaningful RWD-based endpoints. In cancer trials, two real-world endpoints are particularly of interest: real-world overall survival (rwOS) and real-world time to next treatment (rwTTNT). In this work...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d52a713f-8707-5df6-b8d3-d6abc14567f1
DOI: 10.1101/2021.06.10.21258706

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validate Real-World Data-based Endpoint Measures of Cancer Treatment OutcomesDOI 10.1101/2021.06.10.21258706Read

Real-World Data and Evidence in Lung Cancer: A Review of Recent DevelopmentsSemantic proximity Read

Generating real-world tumor burden endpoints from electronic health record data: Comparison of RECIST, radiology-anchored, and clinician-anchored approaches for abstracting real-world progression in non-small cell lung cancerSemantic proximity Read

Electronic patient-reported outcome monitoring system for sarcoma patients undergoing drug treatment: A development and feasibility studySemantic proximity Read

Validation of a Composite Mortality Endpoint in a Large, Clinico-Genomic Real-World Database of Patients with Advanced CancerSemantic proximity Read

Implementing electronic patient reported outcome data capture for multi-centre oncology clinical trialsSemantic proximity Read

Validation and clinical discovery demonstration of a real-world data extraction platformSemantic proximity Read

Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussionSemantic proximity Read

Predicting Individual Responses in Phase I Oncology Trials Using Routinely Collected Clinical BiomarkersSemantic proximity Read

A machine learning approach to predicting short-term mortality risk in patients starting chemotherapySemantic proximity Read

Examining the Feasibility and Functionality of Common Analysis Methods for Longitudinal Data with Binary OutcomesSemantic proximity Read

Pilot Trial of an Electronic Patient-Reported Outcome Monitoring System in Patients with Metastatic Breast Cancer Undergoing ChemotherapySemantic proximity Read

Exploring the discrepancies between clinical trials and real-world data by accounting for Selection criteria, Operations, and Measurements of OutcomeSemantic proximity Read